Imaging of Staphylococcus aureus Infections and Biofilms Using a Selective Covalent Probe for the Unique Serine Hydrolase FphE
Angewandte Chemie International Edition · 2026
DOI: 10.1002/anie.9575966 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2026. Verfasst von Emily C Woods und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Stanford University School of Medicine, Stanford, United States. Hauptthemen laut MEDLINE: Biofilms, Staphylococcus aureus, Staphylococcal Infections, Fluorescent Dyes. Die Arbeit nennt 28 Literaturangaben. Gefördert von: NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Staphylococcus aureus is the leading cause of soft tissue infections which can often be treated with antibiotics. However, it can also cause significant mortality and morbidity from systemic infections and infections of surgical implants. Implant infections typically require invasive surgery, and treatment often necessitates removal of the implant because S. aureus biofilms are extremely difficult to eradicate with antibiotic treatment alone. Therefore, there is a significant need for improved diagnostic tools for rapid, noninvasive confirmation of S. aureus infections. We recently developed an activity‐based probe containing an oxadiazolone electrophile that selectively and covalently labels the S. aureus ‐specific serine hydrolase, FphE. Here we describe a Cy5‐labeled version of the probe, JJ‐OX‐012, and its characterization as an imaging agent for detecting biofilms both in vitro and in vivo. The probe labeled S. aureus biofilms in vitro, with virtually no background labeling of bacteria that lack FphE expression, such as Escherichia coli . Furthermore, using a mouse surgical implant infection model, we demonstrate that JJ‐OX‐012 can be used for noninvasive fluorescent imaging to detect S. aureus biofilms in vivo. Overall, these findings support the potential for using covalent probes targeting FphE as imaging agents for rapid detection and diagnosis of staphylococcal infections in vivo.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Stanford University School of Medicine, Stanford, United States.
- Department of Otolaryngology-Head & Neck Surgery Divisions, Stanford University School of Medicine, Stanford, United States.
- Department of Radiology, Molecular Imaging Program At Stanford, Stanford University School of Medicine, Stanford, United States.
- Department of Chemistry, Stanford University, Stanford, United States.
ORCID-Profile: Emily C Woods, Tulsi Upadhyay, Ki Wan Park, Jianghong Rao, Jeyun Jo, Matthew Bogyo
Förderung
- NIH HHS
- National Institutes of Health
Zitieren
APA
Woods, E. C., Upadhyay, T., Park, K. W., Su, S. P., Xiao, Z., Rao, J., Valdez, T. A., Jo, J., & Bogyo, M. (2026). Imaging of Staphylococcus aureus Infections and Biofilms Using a Selective Covalent Probe for the Unique Serine Hydrolase FphE. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.9575966
Vancouver
Woods EC, Upadhyay T, Park KW, Su SP, Xiao Z, Rao J, et al. Imaging of Staphylococcus aureus Infections and Biofilms Using a Selective Covalent Probe for the Unique Serine Hydrolase FphE. Angewandte Chemie International Edition. 2026. doi:10.1002/anie.9575966
BibTeX
@article{Woods2026,
author = {Woods, Emily C and Upadhyay, Tulsi and Park, Ki Wan and Su, Shih-Po and Xiao, Zhen and Rao, Jianghong and Valdez, Tulio A and Jo, Jeyun and Bogyo, Matthew},
title = {Imaging of Staphylococcus aureus Infections and Biofilms Using a Selective Covalent Probe for the Unique Serine Hydrolase FphE},
journal = {Angewandte Chemie International Edition},
year = {2026},
doi = {10.1002/anie.9575966}
}
EUVIMED